Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles (Q40637990)

22 September 2017

Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles (English)

1 reference

22 September 2017

Lizheng Guo

1

1 reference

22 September 2017

Xiaoyan Lu

2

1 reference

22 September 2017

Sang-Moo Kang

3

1 reference

22 September 2017

Changyi Chen

4

1 reference

22 September 2017

Richard W Compans

5

1 reference

22 September 2017

Qizhi Yao

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

22 September 2017

1 reference

22 September 2017

313

1 reference

22 September 2017

2

1 reference

22 September 2017

502-513

1 reference

Nasal delivery of vaccines

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

The role of IFN in respiratory syncytial virus pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Infection with influenza a virus leads to flu antigen-induced cutaneous anaphylaxis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Murine model for evaluation of protective immunity to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Intranasal immunization with HIV reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Development of novel influenza virus vaccines and vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

The CD4(+) T cell response to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Mucosal immunity to infection with implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Production and characterization of simian--human immunodeficiency virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900372-6

7 January 2021

10.1016/S0042-6822(03)00372-6

Identifiers

DOI

1 reference

22 September 2017

1 reference